Giorgio Stabile
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Giorgio Stabile has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Antonio Podo Brunetti
Dermatology Clinic, IRCCS San Raffaele Hospital, 20132 Milan, Italy
1 shared publication - Cristina Maccario
UB-CARE S.r.l.-Spin-off University of Pavia, 27100 Pavia, Italy
1 shared publication - Franco Rongioletti
Dermatology Clinic, IRCCS San Raffaele Hospital, 20132 Milan, Italy
1 shared publication - Gianmarco Diego Bigotto
Vita-Salute San Raffaele University, Milan, Italy -
1 shared publication - Hassan Galadari
College of Medicine and Health Sciences United Arab Emirates University Al Ain UAE
1 shared publication - Lucia Brambilla
Dermatology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy
1 shared publication
Latest Publications
- Open Access
- 8 September 2023
- Published by MDPI AG in Dermatopathology
- Vol. 10 (3) , 281-286
Lichen Planus Pigmentosus with True Melanocytic Nests: A Case Report with a Comprehensive Literature Review
Lichen Planus Pigmentosus (LPP) is an uncommon variant of lichen planus characterized by the development of dark greyish-brown macules and patches primarily affecting sun-exposed areas. Histologically, it presents with lichenoid interface dermatitis with many melanophages. In select cases, the presence of melanocytic nests or pseudomelanocytic nests within LPP lesions has been documented, posing a diagnostic challenge. We present a detailed case report of a 32-year-old Eritrean woman with a longstanding history of hyperpigmented macules, alongside an in-depth review of the existing literature on lichenoid dermatoses featuring melanocytic or pseudomelanocytic nests. This paper delves into the clinical presentation, histopathological features, differential diagnosis, and potential mechanisms underlying this intriguing phenomenon.
- 8 September 2023
- Published by MDPI AG in Dermatopathology
- Vol. 10 (3) , 281-286
Open AccessLichen Planus Pigmentosus with True Melanocytic Nests: A Case Report with a Comprehensive Literature Review
Lichen Planus Pigmentosus (LPP) is an uncommon variant of lichen planus characterized by the development of dark greyish-brown macules and patches primarily affecting sun-exposed areas. Histologically, it presents with lichenoid interface dermatitis with many melanophages. In select cases, the presence of melanocytic nests or pseudomelanocytic nests within LPP lesions has been documented, posing a diagnostic challenge. We present a detailed case report of a 32-year-old Eritrean woman with a longstanding history of hyperpigmented macules, alongside an in-depth review of the existing literature on lichenoid dermatoses featuring melanocytic or pseudomelanocytic nests. This paper delves into the clinical presentation, histopathological features, differential diagnosis, and potential mechanisms underlying this intriguing phenomenon.
- Open Access
- 27 April 2023
- Published by MDPI AG in Pharmaceuticals
- Vol. 16 (5) , 655
Investigation on the Biological Safety and Activity of a Gluconolactone-Based Lotion for Dermocosmetic Application
(1) Background: Cosmeceuticals are formulas enriched with active ingredients that exert efficacy on different skin molecular targets. (2) Methods: Cell viability and the absence of potential irritant risk were evaluated on keratinocytes (HaCaT), fibroblasts (NHDF), adipocytes (3T3-L1), sebocytes (PCi-SEB_CAU) and reconstructed human epidermis (RHE), respectively. Several treatments were performed to evaluate the ability of the lotion to stimulate the production of collagen and elastin, stimulate the differentiation of keratinocytes and reduce the number of senescent cells following UVB stimulation. In addition, the modulation of genes involved in the production, storage and accumulation of sebum were investigated. (3) Results: The results obtained demonstrated the biosafety of the formula in all cell lines tested. The 24-h treatment with non-cytotoxic concentrations determined an increase in the expression of the collagen (COL1A1), elastin (ELN) and involucrin (IVL) genes, while a reduction of peroxisome proliferator-activated receptor-gamma (PPARγ) gene expression and a reduction of SA-βgal-positive cells were found. Moreover, the treatment did not interfere with normal steroid 5-alpha reductase (5RDA3) gene expression levels. (4) Conclusions: Data collected demonstrated the biosafety of the lotion, the non-comedogenic property and a multi targets anti-aging effect. In particular, data collected on the booster lotion make it a valid way to counteract the pore dilatation aging related.
- 27 April 2023
- Published by MDPI AG in Pharmaceuticals
- Vol. 16 (5) , 655
Open AccessInvestigation on the Biological Safety and Activity of a Gluconolactone-Based Lotion for Dermocosmetic Application
(1) Background: Cosmeceuticals are formulas enriched with active ingredients that exert efficacy on different skin molecular targets. (2) Methods: Cell viability and the absence of potential irritant risk were evaluated on keratinocytes (HaCaT), fibroblasts (NHDF), adipocytes (3T3-L1), sebocytes (PCi-SEB_CAU) and reconstructed human epidermis (RHE), respectively. Several treatments were performed to evaluate the ability of the lotion to stimulate the production of collagen and elastin, stimulate the differentiation of keratinocytes and reduce the number of senescent cells following UVB stimulation. In addition, the modulation of genes involved in the production, storage and accumulation of sebum were investigated. (3) Results: The results obtained demonstrated the biosafety of the formula in all cell lines tested. The 24-h treatment with non-cytotoxic concentrations determined an increase in the expression of the collagen (COL1A1), elastin (ELN) and involucrin (IVL) genes, while a reduction of peroxisome proliferator-activated receptor-gamma (PPARγ) gene expression and a reduction of SA-βgal-positive cells were found. Moreover, the treatment did not interfere with normal steroid 5-alpha reductase (5RDA3) gene expression levels. (4) Conclusions: Data collected demonstrated the biosafety of the lotion, the non-comedogenic property and a multi targets anti-aging effect. In particular, data collected on the booster lotion make it a valid way to counteract the pore dilatation aging related.